Ebola Vaccine, Drug Under Investigation
News outlets discuss a potential vaccine and treatment for Ebola.
ABC News: How an Ebola Vaccine Could Change the Next Deadly Outbreak
“As Ebola ravages West Africa … officials are desperate for a way to stop the spread of the disease. One possible way to curb the infections is the use of a vaccine that would inoculate those at risk. In September an Ebola vaccine developed by the U.S. National Institute for Health will be tested in humans for the first time in its first phase 1 clinical trial. If approved, it could be ready for use by mid to late 2015…” (Mohney, 8/3).
The Hill: Secret drug might have saved Ebola patients
“A top-secret experimental drug was flown to Liberia last week and likely saved the lives of U.S. missionary workers who have contracted Ebola, CNN reported Monday. The drug, called ZMapp, was sent by a representative from the National Institutes of Health to Samaritan’s Purse, the aid organization Dr. Kent Brantly [an American infected with Ebola] works for in Liberia…” (Shabad, 8/4).
Time: We’re Getting Closer to Vaccines and Drugs for Ebola
“On Monday, National Institutes of Health immunologist Dr. Anthony Fauci told CBS This Morning that his research team is working on a vaccine to prevent Ebola, which is completely effective in monkeys, and will be tested in humans in September. And he’s not the only one developing a treatment for the deadly disease. The question is: Should experimental treatments be rushed into practice, given the breadth of this outbreak?” (Park, 8/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.